Brief: Pfizer Reaffirms FY2026 Guidance Following CFO Transition Announcement
18/06/2026 18:33
BRIEF-Pfizer Reaffirms FY2026 Guidance Following CFO Transition Announcement June 18 (Reuters) - Pfizer Inc PFE.N:
PFIZER - REAFFIRMS FY2026 GUIDANCE FOLLOWING CFO TRANSITION ANNOUNCEMENT - SEC FILING
Source text: [ID:n0000078003-26-000087]
Further company coverage: PFE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials